C9782 — Blinded procedure for new york heart association (nyha) class ii or iii heart failure, or canadian cardiovascular society (ccs) class iii or iv chronic refractory angina; transcatheter intramyocardial transplantation of autologous bone marrow cells (e.g., mononuclear) or placebo control, autologous bone marrow harvesting and preparation for transplantation, left heart catheterization including ventriculography, all laboratory services, and all imaging with or without guidance (e.g., transthoracic echocardiography, ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) studyHCPCS/CPT
No Prior Auth Required
No active coverage policies found for this code (low confidence)
CIGNA-0287 — Cell-Based Therapy for Cardiac and Peripheral Arterial Disease - (0287)
AETNA-CPB-0599 — Autologous Skeletal Myoblast/Mononuclear Bone Marrow Cell Transplantation
BCBSIL-SUR703.027 — Progenitor Cell Therapy for the Treatment of Damaged Myocardium Due to Ischemia
BCBSMT-SUR703.027 — Progenitor Cell Therapy for the Treatment of Damaged Myocardium Due to Ischemia
BCBSNM-SUR703.027 — Progenitor Cell Therapy for the Treatment of Damaged Myocardium Due to Ischemia
BCBSOK-SUR703.027 — Progenitor Cell Therapy for the Treatment of Damaged Myocardium Due to Ischemia
SUR703.027 — Progenitor Cell Therapy for the Treatment of Damaged Myocardium Due to Ischemia